Triple

T4616992
Position Surface form Disambiguated ID Type / Status
Subject Hazard Analysis and Critical Control Point E100890 entity
Predicate relatedTo P37 FINISHED
Object Good Manufacturing Practices
Good Manufacturing Practices are a set of regulatory and industry standards that ensure products are consistently produced and controlled to quality and safety requirements, particularly in sectors like food, pharmaceuticals, and cosmetics.
E458509 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Good Manufacturing Practices | Statement: [Hazard Analysis and Critical Control Point, relatedTo, Good Manufacturing Practices]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Good Manufacturing Practices
Context triple: [Hazard Analysis and Critical Control Point, relatedTo, Good Manufacturing Practices]
  • A. ICH Q10 Pharmaceutical Quality System
    ICH Q10 Pharmaceutical Quality System is an international guideline that establishes a comprehensive, lifecycle-based framework for pharmaceutical quality management to ensure consistent product quality and regulatory compliance.
  • B. Office of Pharmaceutical Quality
    The Office of Pharmaceutical Quality is a U.S. Food and Drug Administration office responsible for ensuring the quality, safety, and consistency of human drugs throughout their lifecycle.
  • C. ISO 13485
    ISO 13485 is an international quality management standard that specifies requirements for organizations involved in the design, production, installation, and servicing of medical devices and related services.
  • D. ICH Q8 Pharmaceutical Development
    ICH Q8 Pharmaceutical Development is an international guideline that outlines a systematic, science- and risk-based approach to pharmaceutical product and process development, forming a core part of the ICH quality framework.
  • E. Quality Control
    Quality Control is an Atlanta-based hip-hop record label and management company known for developing major rap artists such as Migos, Lil Baby, and City Girls.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Good Manufacturing Practices
Triple: [Hazard Analysis and Critical Control Point, relatedTo, Good Manufacturing Practices]
Generated description
Good Manufacturing Practices are a set of regulatory and industry standards that ensure products are consistently produced and controlled to quality and safety requirements, particularly in sectors like food, pharmaceuticals, and cosmetics.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Good Manufacturing Practices
Target entity description: Good Manufacturing Practices are a set of regulatory and industry standards that ensure products are consistently produced and controlled to quality and safety requirements, particularly in sectors like food, pharmaceuticals, and cosmetics.
  • A. ICH Q10 Pharmaceutical Quality System
    ICH Q10 Pharmaceutical Quality System is an international guideline that establishes a comprehensive, lifecycle-based framework for pharmaceutical quality management to ensure consistent product quality and regulatory compliance.
  • B. Office of Pharmaceutical Quality
    The Office of Pharmaceutical Quality is a U.S. Food and Drug Administration office responsible for ensuring the quality, safety, and consistency of human drugs throughout their lifecycle.
  • C. ISO 13485
    ISO 13485 is an international quality management standard that specifies requirements for organizations involved in the design, production, installation, and servicing of medical devices and related services.
  • D. ICH Q8 Pharmaceutical Development
    ICH Q8 Pharmaceutical Development is an international guideline that outlines a systematic, science- and risk-based approach to pharmaceutical product and process development, forming a core part of the ICH quality framework.
  • E. Quality Control
    Quality Control is an Atlanta-based hip-hop record label and management company known for developing major rap artists such as Migos, Lil Baby, and City Girls.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69bd43cf363c819087fd5ab441b4a3f4 completed March 20, 2026, 12:55 p.m.
NER Named-entity recognition batch_69bd59e098c08190b769e76937dff700 completed March 20, 2026, 2:29 p.m.
NED1 Entity disambiguation (via context triple) batch_69bdfa8da23881909ba4a70e9697f260 completed March 21, 2026, 1:55 a.m.
NEDg Description generation batch_69bdfc7b84108190af39c7780f702745 completed March 21, 2026, 2:03 a.m.
NED2 Entity disambiguation (via description) batch_69bdfd3856b48190a44f49da5fde38f6 completed March 21, 2026, 2:06 a.m.
Created at: March 20, 2026, 1:12 p.m.